Key result
Elevated BNP is linked to increased long-term mortality in adult congenital heart disease.
Why the study?
Many adult patients with congenital heart disease experience premature death, and previous reports suggested natriuretic peptides may identify those with adverse outcomes.
Do B-type natriuretic peptide (BNP) levels predict long-term mortality in adults with congenital heart disease?
Do B-type natriuretic peptide (BNP) levels predict long-term mortality in adults with congenital heart disease?
The study investigates the prognostic power of BNP for long-term mortality in adults with congenital heart disease.
Answers are grounded in this paper and cite their sources.
May support BNP for risk stratification in adult congenital heart disease; leaves open prospective validation and intervention trials.
Many adult patients with congenital heart disease (ACHD) are still afflicted by premature death. Previous reports suggested natriuretic peptides may identify ACHD patients with adverse outcome. The study investigated prognostic power of B-type natriuretic peptide (BNP) across the spectrum of ACHD in a large contemporary cohort.
No takes yet. Share an insight, caveat, or question.
Yumita et al. (2024) studied this question. B-type natriuretic peptide levels predict long-term mortality in adults with congenital heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: